Cytodyn named top 4 choices for a possible corona
Post# of 148165
Regeneron: Market capitalization $ 64 billion
Gilead Sciences: Market capitalization $ 96.7 billion
GlaxoSmithKline: Market capitalization $ 96.5 billion
far behind (ironically meant)
Cytodyn: market capitalization $ 1.44 billion.
There should still be a little bit of potential for Cytodyn!
What do you think !?!?
https://finance.yahoo.com/news/biotech-compan...12489.html